Crystal Dawn Karakochuk

Assistant Professor

Research Classification

Research Interests

Nutrition
Global Health and Emerging Diseases
Hematology
Biochemical markers of iron status
Clinical dietetics
Determinants and causes of anemia
Inherited blood disorders (sickle cell, thalassemia, glucose-6-phosphate dehydrogenase deficiency)
International nutrition
Maternal and child nutrition
Micronutrients (namely iron, folic acid, and zinc)
Risk-benefit of micronutrient supplementation

Relevant Degree Programs

Affiliations to Research Centres, Institutes & Clusters

Research Options

I am available and interested in collaborations (e.g. clusters, grants).
I am interested in and conduct interdisciplinary research.
 
 

Research Methodology

Randomized Controlled Trials
Nutritional surveys
Human intervention studies
biomarkers

Recruitment

Master's students
Doctoral students
Postdoctoral Fellows
2024
I support public scholarship, e.g. through the Public Scholars Initiative, and am available to supervise students and Postdocs interested in collaborating with external partners as part of their research.
I support experiential learning experiences, such as internships and work placements, for my graduate students and Postdocs.
I am open to hosting Visiting International Research Students (non-degree, up to 12 months).

Complete these steps before you reach out to a faculty member!

Check requirements
  • Familiarize yourself with program requirements. You want to learn as much as possible from the information available to you before you reach out to a faculty member. Be sure to visit the graduate degree program listing and program-specific websites.
  • Check whether the program requires you to seek commitment from a supervisor prior to submitting an application. For some programs this is an essential step while others match successful applicants with faculty members within the first year of study. This is either indicated in the program profile under "Admission Information & Requirements" - "Prepare Application" - "Supervision" or on the program website.
Focus your search
  • Identify specific faculty members who are conducting research in your specific area of interest.
  • Establish that your research interests align with the faculty member’s research interests.
    • Read up on the faculty members in the program and the research being conducted in the department.
    • Familiarize yourself with their work, read their recent publications and past theses/dissertations that they supervised. Be certain that their research is indeed what you are hoping to study.
Make a good impression
  • Compose an error-free and grammatically correct email addressed to your specifically targeted faculty member, and remember to use their correct titles.
    • Do not send non-specific, mass emails to everyone in the department hoping for a match.
    • Address the faculty members by name. Your contact should be genuine rather than generic.
  • Include a brief outline of your academic background, why you are interested in working with the faculty member, and what experience you could bring to the department. The supervision enquiry form guides you with targeted questions. Ensure to craft compelling answers to these questions.
  • Highlight your achievements and why you are a top student. Faculty members receive dozens of requests from prospective students and you may have less than 30 seconds to pique someone’s interest.
  • Demonstrate that you are familiar with their research:
    • Convey the specific ways you are a good fit for the program.
    • Convey the specific ways the program/lab/faculty member is a good fit for the research you are interested in/already conducting.
  • Be enthusiastic, but don’t overdo it.
Attend an information session

G+PS regularly provides virtual sessions that focus on admission requirements and procedures and tips how to improve your application.

 

Great Supervisor Week Mentions

Each year graduate students are encouraged to give kudos to their supervisors through social media and our website as part of #GreatSupervisorWeek. Below are students who mentioned this supervisor since the initiative was started in 2017.

 

Crystal has always been extremely supportive and encouraging as a supervisor. She is very easy to talk to and I always feel comfortable to go to her with questions. I know she has my best interest in mind and genuinely cares about my success as a grad student. She is definitely a great supervisor!!!

Kelsey Cochrane (2019)

 

Graduate Student Supervision

Master's Student Supervision

Theses completed in 2010 or later are listed below. Please note that there is a 6-12 month delay to add the latest theses.

Evaluating the effect of 12 weeks of supplementation with ferrous sulfate, ferrous bisglycinate or placebo, on iron status and gut inflammation in Cambodian women (2021)

The WHO recommends 12 weeks daily iron supplementation for women in countries where anemia prevalence is ≥40%, such as in Cambodia. However, if iron deficiency is not a major cause of anemia, then, at best, untargeted iron supplementation is a waste of resources; at worst, it could cause harm. My aim was to assess the non-inferiority of 12 weeks of ferrous sulfate and ferrous bisglycinate supplementation on ferritin concentrations and the effect on gut inflammation concentrations in Cambodian women, as compared to placebo. A double-blind, three-arm, randomized controlled trial was conducted in Kampong Thom province, Cambodia. Non-pregnant women (n=480, 18-45 years) were randomized to receive 60 mg ferrous sulfate, 18 mg ferrous bisglycinate, or placebo. Non-fasting blood and stool samples were collected at baseline and 12 weeks. Ferritin was measured with an ELISA, and values were adjusted for inflammation. Fecal calprotectin was measured as an indicator of gut inflammation with use of an ELISA kit (BÜHLMANN fCAL®). Mixed-effects generalized linear models were used to assess the effect of the two iron interventions on ferritin and fecal calprotectin concentration at 12 weeks, as compared to placebo. A total of 480 women were enrolled with 88% (n=421) trial retention at 12 weeks. Our non-inferiority analysis was inconclusive to determine if ferrous bisglycinate was non-inferior to ferrous sulfate, as the CI for our predicted mean difference in ferritin concentrations between the two iron interventions crossed our ‘a priori’ defined margin of non-inferiority (20 μg/L). In a secondary analysis with use of a superiority approach, mean ferritin concentration at 12 weeks was significantly higher in the ferrous sulfate group (98.6 [94.7,102.6] µg/L, P
View record

The effect of once weekly folic acid supplementation on red blood cell folate concentrations in women to determine the potential to prevent neural tube defects (2020)

In populations where the prevalence of anemia is >20% in women of reproductive age, the World Health Organization (WHO) recommends weekly supplementation with 60 mg iron and 2.8 mg folic acid as an anemia prevention strategy. Folic acid was included in this weekly supplement not only for anemia prevention, but also to reduce the risk of neural tube defects (NTD) should a woman become pregnant. The dose of folic acid is equivalent to seven times the daily dose of folic acid shown to reduce the risk of NTDs in controlled trials (0.4 mg x 7 days = 2.8 mg). However, the majority of currently-used weekly supplements contain 0.4 mg of folic acid (the daily recommended dose in pregnancy). There is a lack of evidence to support if a weekly 2.8 mg dose of folic acid is more effective at raising red blood cell (RBC) folate concentrations to a level associated with a reduced risk of NTD (>748 nmol/L) than the current practice of weekly 0.4 mg folic acid. In this three-arm randomized controlled trial, we randomized n=331 non-pregnant Malaysian women (18-45 y) to receive 60 mg iron and either 2.8, 0.4, or 0 mg folic acid. RBC and plasma folate were measured at baseline, 16 weeks, and 4 weeks after the discontinuation of the intervention. Following 16 weeks of intervention, the primary outcome of mean RBC folate in the 2.8 mg folic acid per week group was significantly higher than the 0.4 mg and 0 mg groups [mean difference (95% CI) 271 (234, 309) and 355 (316, 394) nmol/L, respectively (P
View record

Investigating the potential risk of untargeted daily oral iron supplementation in Cambodian women of reproductive age (2019)

Background: There is limited evidence regarding the potential risk of untargeted daily oral iron supplementation in women of reproductive age, especially in countries where genetic hemoglobinopathies are common and iron deficiency is not the major cause of anemia. Excess iron exposure can cause increased production of reactive oxygen species (ROS), which can lead to cellular (e.g. lipid, DNA) damage. Objective: The aim of this research was to retrospectively assess the effect of daily oral iron supplementation with 60 mg of elemental iron for 12 weeks, compared to placebo, on relative leukocyte telomere length (LTL) and mitochondrial DNA (mtDNA) content. Methods: In a double-blind randomized controlled trial, non-pregnant Cambodian women aged 18–45 years received 60 mg of elemental iron as ferrous sulphate (n = 201) or a placebo (n = 200) for 12 weeks. Relative LTL and mtDNA content were quantified in buffy coat collected at baseline and endline by monochrome multiplex quantitative polymerase chain reaction (MMqPCR) and the change in relative LTL and mtDNA content was determined. Results: Iron supplementation was not associated with an adjusted absolute or percent change in relative LTL after 12 weeks, compared to placebo (ß-coefficient: −0.04 [95% CI: −0.16, 0.08]; P = 0.50 and ß-coefficient: −0.96 [95% CI: −2.69, 0.77]; P = 0.28, respectively). However, iron supplementation was associated with a significantly smaller adjusted absolute and percent increase in mtDNA content after 12 weeks, compared to placebo (ß-coefficient: −11 [95% CI: −20, −2]; P = 0.02 and ß-coefficient: −11 [95% CI: −20, −1]; P = 0.02, respectively). Conclusions: Our findings suggest that daily oral iron supplementation with 60 mg of elemental iron for 12 weeks, as per the World Health Organization (WHO) global policy, may be associated with altered mitochondrial homeostasis. This is concerning and more research is needed to ascertain if there is potential risk associated with untargeted daily oral iron supplementation, to ultimately inform the safety of the WHO policy.

View record

Publications

 
 

If this is your researcher profile you can log in to the Faculty & Staff portal to update your details and provide recruitment preferences.

 
 

Get key application advice, hear about the latest research opportunities and keep up with the latest news from UBC's graduate programs.